Publication | Closed Access

Characterization of cAMP-dependent inhibition of LPS-induced TNFα production by rolipram, a specific phosphodiesterase IV (PDE IV) inhibitor

Molecular PharmacologySignal TransductionBiochemistryMedicinePde IvImmunologyMechanism Of ActionCellular PharmacologyCamp-dependent InhibitionPharmacotherapyLps-induced Tnfα ProductionPharmacologyCell SignalingInhibitory ActivityProtein PhosphorylationDrug Discovery